Oral tungstate (Na2WO4) exposure reduces adaptive immune responses in mice after challenge

Journal of Immunotoxicology

Volumn 11, Issue 2, 2014, Pages 148-159

  Osterburg, Andrew R ^a   Robinson, Chad T ^a   Mokashi, Vishwesh ^b   Stockelman, Michael ^c   Schwemberger, Sandy J ^d   Chapman, Gail ^e   Babcock, George F ^a,f  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NMRC Frederick   (United States)

^c NAVAL RESEARCH LABORATORY   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e Military Infectious Disease Research Program Naval Medical Research and Development Command (M2)   (United States)

^f SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Cytotoxic T cell; Helper T cell; Immune response; Immunophenotyping; SEB; Sodium tungstate; Staphylococcal enterotoxin B; Tungsten

Indexed keywords

CD71 ANTIGEN; DRINKING WATER; SODIUM CHLORIDE; STAPHYLOCOCCUS ENTEROTOXIN B; TUNGSTATE SODIUM; TUNGSTEN; UNCLASSIFIED DRUG; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; GAMMA INTERFERON; SODIUM TUNGSTATE(VI); TUNGSTEN DERIVATIVE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; EXPOSURE; FLOW CYTOMETRY; FOOT PAD; HELPER CELL; HEMATOLOGICAL PARAMETERS; HOST RESISTANCE; IMMUNOPHENOTYPING; IMMUNOTOXICITY; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECTS; FEMALE; IMMUNOLOGY; ORAL DRUG ADMINISTRATION;

ADAPTIVE IMMUNITY; ADMINISTRATION, ORAL; ANIMALS; ENTEROTOXINS; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNOPHENOTYPING; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TUNGSTEN COMPOUNDS;

EID: 84897886382     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2013.816394     Document Type: Article

References (55)

1. Amigo-Correig, M., Barcelo-Batillori, S., Piquer, S., et al. 2011. Sodium tungstate regulates food intake and body weight through activation of the hypothalamic leptin pathway. Diabetes Obes. Metab. 13:235-242.
2. Babcock, G. F., and Dawes, S. M. 1994. Immunophenotyping using fixed cells. Meth. Cell Biol. 41:81-93.
3. Bommireddy, R., Saxena, V., Ormsby, I., et al. 2003. TGF-b1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J. Immunol. 170:4612-4622.
4. Briner, W. 2010. The toxicity of depleted uranium. Int. J. Environ. Res. Publ. Health. 7:303-313.
5. Briner, W. E. 2006. The evolution of depleted uranium as an environmental risk factor: Lessons from other metals. Int. J. Environ. Res. Publ. Health. 3:129-135.
6. Chen, Y., Jakoncic, J., Carpino, N., and Nassar, N. 2009. Structural and functional characterization of the 2H-phosphatase domain of Sts-2 reveals an acid-dependent phosphatase activity. Biochemistry. 48: 1681-1690.
7. Clausen, J. L., and Korte, N. 2009. Environmental fate of tungsten from military use. Sci. Total Environ. 407:2887-2893.
8. Dominguez, J. E., Munoz, M. C., Zafra, D., et al. 2003. The anti-diabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. J. Biol. Chem. 278:42785-42794.
9. Egloff, M. P., Cohen, P. T., Reinemer, P., and Barford, D. 1995. Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate. J. Mol. Biol. 254:942-959.
10. Fang, J., Seki, T., Qin, H., et al. 2010. Tissue protective effect of xanthine oxidase inhibitor, polymer conjugate of (styrene-,maleic acid copolymer) and (4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine), on hepatic ischemia-reperfusion injury. Exp. Biol. Med. (Maywood). 235: 487-496.
11. Fastje, C. D., Harper, K., Terry, C., et al. 2011. Exposure to sodium tungstate and Respiratory Syncytial Virus results in hematological/immunological disease in C57BL/6J mice. Chem. Biol. Interact. 196:89-95.
12. Fastje, C. D., Kim, L., Sun, N. N., et al. 2009. Prenatal exposure of mice to tungstate is associated with decreased transcriptome-expression of the putative tumor suppressor gene, DMBT1: Implications for childhood leukemia. Land. Contam. Reclam. 17:169-178.
13. Gomez-Ramos, A., Dominguez, J., Zafra, D., et al. 2006. Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation. J. Neurosci. Res. 83:264-273.
14. Guandalini, G. S., Zhang, L., Fornero, E., et al. 2011. Tissue distribution of tungsten in mice following oral exposure to sodium tungstate. Chem. Res. Toxicol. 24:488-493.
15. Hanzu, F., Gomis, R., Coves, M. J., et al. 2010. Proof-of-concept trial on the efficacy of sodium tungstate in human obesity. Diabetes Obes. Metab. 12:1013-1018.
16. Horiuchi, H., Ota, M., Kitahara, S., et al. 1999. Allopurinol increases ear swelling and mortality in a dinitrofluorobenzene-induced contact hypersensitivity mouse model. Biol. Pharm. Bull. 22:810-815.
17. Johnson, D. R., Ang, C., Bednar, A. J., and Inouye, L. S. 2010. Tungsten effects on phosphate-dependent biochemical pathways are species and liver cell line dependent. Toxicol. Sci. 116:523-532.
18. Johnson, J. L., Rajagopalan, K. V., and Cohen, H. J. 1974. Molecular basis of the biological function of molybdenum. Effect of tungsten on xanthine oxidase and sulfite oxidase in the rat. J. Biol. Chem. 249: 859-866.
19. Kalinich, J. F., Emond, C. A., Dalton, T. K., et al. 2005. Embedded weapons-grade tungsten alloy shrapnel rapidly induces metastatic highgrade rhabdomyosarcomas in F344 rats. Environ. Health Perspect. 113: 729-734.
20. Kato, C., Sato, K., Wakabayashi, A., and Eishi, Y. 2000. The effects of allopurinol on immune function in normal BALB/c and SCID mice. Int. J. Immunopharmacol. 22:547-556.
21. Krakauer, T. 2005. Chemotherapeutics targeting immune activation by staphylococcal super-antigens. Med. Sci. Monit. 11:RA290-295.
22. Leggett, R. W. 1997. A model of the distribution and retention of tungsten in the human body. Sci. Total Environ. 206:147-165.
23. Ligtenberg, A. J., Veerman, E. C., Nieuw Amerongen, A. V., and Mollenhauer, J. 2007. Salivary agglutinin/glycoprotein-340/DMBT1: A single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol. Chem. 388: 1275-1289.
24. Luo, Y., and Dorf, M. E. 2001. Delayed-type hypersensitivity. In: Current Protocols in Immunology. (Bierer, B. E., Coligan, J. E., Margulies, D. H., Shevach, E. M., and Strober, W., eds., Somerset, NJ: John Wiley & Sons. Chapter 4, Unit 45.
25. Maemura, K., Zheng, Q., Wada, T., et al. 2005. Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunol. Cell. Biol. 83:336-343.
26. Marquet, P., Francois, B., Lotfi, H., et al. 1997. Tungsten determination in biological fluids, hair, and nails by plasma emission spectrometry in a case of severe acute intoxication in man. J. Forensic Sci. 42:527-530.
27. Marquet, P., Francois, B., Vignon, P., and Lachatre, G. 1996. A soldier who had seizures after drinking quarter of a litre of wine. Lancet. 348: 1070.
28. Matsue, H., Edelbaum, D., Shalhevet, D., et al. 2003. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171:3010-3018.
29. McInturf, S. M., Bekkedal, M. Y., Wilfong, E., et al. 2011. The potential reproductive, neurobehavioral and systemic effects of soluble sodium tungstate exposure in Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 254:133-137.
30. Miyakawa, H., Sato, K., Shinbori, T., et al. 2002. Effects of inducible nitric oxide synthase and xanthine oxidase inhibitors on SEB-induced interstitial pneumonia in mice. Eur. Respir. J. 19:447-457.
31. Mollenhauer, J., Herbertz, S., Holmskov, U., et al. 2000. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 60:1704-1710.
32. Munoz, M. C., Barbera, A., Dominguez, J., et al. 2001. Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. Diabetes. 50:131-138.
33. Nguyen, X. D., Eichler, H., Dugrillon, A., et al. 2003. Flow cytometric analysis of T-cell proliferation in a mixed lymphocyte reaction with dendritic cells. J. Immunol. Meth. 275:57-68.
34. Nielsen, V. G., Tan, S., Baird, M. S., et al. 1997. Xanthine oxidase mediates myocardial injury after hepatoenteric ischemia-reperfusion. Crit. Care Med. 25:1044-1050.
35. Nishino, T., Okamoto, K., Eger, B. T., and Pai, E. F. 2008. Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 275:3278-3289.
36. Ono, T., Tsuruta, R., Fujita, M., et al. 2009. Xanthine oxidase is one of the major sources of superoxide anion radicals in blood after reperfusion in rats with forebrain ischemia/reperfusion. Brain Res. 1305: 158-167.
37. Osterburg, A. R., Robinson, C. T., Schwemberger, S., et al. 2010. Sodium tungstate (Na2WO4) exposure increases apoptosis in human peripheral blood lymphocytes. J. Immunotoxicol. 7:174-182.
38. Pacher, P., Nivorozhkin, A., and Szabo, C. 2006. Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol. Rev. 58:87-114.
39. Peglow, S., Toledo, A. H., Anaya-Prado, R., et al. 2011. Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion. J. Hepatobil. Pancreat. Sci. 18:137-146.
40. Pichler, W. J. 2003. Delayed drug hypersensitivity reactions. Ann. Intern. Med. 139:683-693.
41. Piquer, S., Barcelo-Batillori, S., Julia, M., et al. 2007. Phosphorylation events implicating p38 and PI3K mediate tungstate-effects in MIN6 beta cells. Biochem. Biophys. Res. Commun. 358:385-391.
42. Premaud, A., Rousseau, A., Johnson, G., et al. 2011. Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships. Pharmacol. Res. 63: 432-438.
43. Pyatt, F. B., and Pyatt, A. J. 2004. The bioaccumulation of tungsten and copper by organisms inhabiting metalliferous areas in North Queensland, Australia: An evaluation of potential health implications. J. Environ. Health Res. 3:13-18.
44. Rodriguez-Hernandez, C. J., Guinovart, J. J., and Murguia, J. R. 2012. Anti-diabetic and anti-obesity agent sodium tungstate enhances GCN pathway activation through Glc7p inhibition. FEBS Lett. 586:270-276.
45. Rubin, C. S., Holmes, A. K., Belson, M. G., et al. 2007. Investigating childhood leukemia in Churchill County, Nevada. Environ. Health Perspect. 115:151-157.
46. Sklavos, M. M., Tse, H. M., and Piganelli, J. D. 2008. Redox modulation inhibits CD8 T-cell effector function. Free Rad. Biol. Med. 45: 1477-1486.
47. Steinberg, K. K., Relling, M. V., Gallagher, M. L., et al. 2007. Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada. Environ. Health Perspect. 115:158-164.
48. Strigul, N., Koutsospyros, A., and Christodoulatos, C. 2010. Tungsten speciation and toxicity: Acute toxicity of mono- and poly-tungstates to fish. Ecotoxicol. Environ. Saf. 73:164-171.
49. Tse, H. M., Milton, M. J., and Piganelli, J. D. 2004. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigenpresenting cells: Implication for their use in targeting oxidationreduction reactions in innate immunity. Free Rad. Biol. Med. 36: 233-247.
50. Umezawa, K., Akaike, T., Fujii, S., et al. 1997. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the anti-microbial mechanism against Salmonella typhimurium infection in mice. Infect. Immun. 65:2932-2940.
51. Verma, R., Xu, X., Jaiswal, M. K., et al. 2011. In vitro profiling of epigenetic modifications underlying heavy metal toxicity of tungsten-alloy and its components. Toxicol. Appl. Pharmacol. 253: 178-187.
52. Vorbach, C., Harrison, R., and Capecchi, M. R. 2003. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol. 24:512-517.
53. Wilson, B., and Pyatt, F. B. 2006. Bio-availability of tungsten in the vicinity of an abandoned mine in the English Lake District and some potential health implications. Sci. Total Environ. 370:401-408.
54. Wright, R. M., Ginger, L. A., Kosila, N., et al. 2004. Mononuclear phagocyte xanthine oxidoreductase contributes to cytokine-induced acute lung injury. Am. J. Respir. Cell. Mol. Biol. 30:479-490.
55. Yang, J., Liang, X., Niu, T., et al. 1998. Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1. J. Biol. Chem. 273: 28199-28207.